NO20053247L - Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt. - Google Patents

Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.

Info

Publication number
NO20053247L
NO20053247L NO20053247A NO20053247A NO20053247L NO 20053247 L NO20053247 L NO 20053247L NO 20053247 A NO20053247 A NO 20053247A NO 20053247 A NO20053247 A NO 20053247A NO 20053247 L NO20053247 L NO 20053247L
Authority
NO
Norway
Prior art keywords
levocetirizine
treatment
allergic rhinitis
persistent allergic
persistent
Prior art date
Application number
NO20053247A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053247D0 (no
Inventor
Christophe Revirron
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32405747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053247(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of NO20053247D0 publication Critical patent/NO20053247D0/no
Publication of NO20053247L publication Critical patent/NO20053247L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20053247A 2002-12-03 2005-07-01 Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt. NO20053247L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02080064 2002-12-03
PCT/EP2003/005491 WO2004050094A1 (en) 2002-12-03 2003-05-26 Use of levocetirizine for the treatment of persistent allergic rhinitis

Publications (2)

Publication Number Publication Date
NO20053247D0 NO20053247D0 (no) 2005-07-01
NO20053247L true NO20053247L (no) 2005-07-01

Family

ID=32405747

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053247A NO20053247L (no) 2002-12-03 2005-07-01 Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.

Country Status (26)

Country Link
US (1) US20060247258A1 (de)
EP (1) EP1569650B1 (de)
JP (1) JP2006509773A (de)
KR (1) KR20050085298A (de)
CN (1) CN1713912A (de)
AT (1) ATE396730T1 (de)
AU (1) AU2003238399B2 (de)
BR (1) BR0316823A (de)
CA (1) CA2506965A1 (de)
CR (1) CR7835A (de)
CY (1) CY1108191T1 (de)
DE (1) DE60321377D1 (de)
DK (1) DK1569650T3 (de)
ES (1) ES2304514T3 (de)
HR (1) HRP20050497B1 (de)
MA (1) MA27530A1 (de)
MX (1) MXPA05005795A (de)
NO (1) NO20053247L (de)
NZ (1) NZ540415A (de)
PL (1) PL377470A1 (de)
PT (1) PT1569650E (de)
RU (1) RU2005121130A (de)
SI (1) SI1569650T1 (de)
TN (1) TNSN05154A1 (de)
WO (1) WO2004050094A1 (de)
ZA (1) ZA200503703B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2122042T3 (es) * 1992-09-24 1998-12-16 Sepracor Inc Tratamiento de rinitis alergica y asma que emplea (-)cetirizina.
US20030236275A1 (en) * 2002-06-20 2003-12-25 Schering Corporation Treatment methods of nasal congestion and nasal obstruction

Also Published As

Publication number Publication date
NO20053247D0 (no) 2005-07-01
MA27530A1 (fr) 2005-09-01
PT1569650E (pt) 2008-06-26
ATE396730T1 (de) 2008-06-15
CR7835A (es) 2008-12-01
CY1108191T1 (el) 2012-05-23
HRP20050497A2 (en) 2005-12-31
ZA200503703B (en) 2006-10-25
HRP20050497B1 (hr) 2008-10-31
SI1569650T1 (sl) 2008-08-31
EP1569650B1 (de) 2008-05-28
WO2004050094A1 (en) 2004-06-17
TNSN05154A1 (en) 2007-05-14
NZ540415A (en) 2008-06-30
JP2006509773A (ja) 2006-03-23
AU2003238399B2 (en) 2009-05-07
EP1569650A1 (de) 2005-09-07
MXPA05005795A (es) 2005-08-16
US20060247258A1 (en) 2006-11-02
PL377470A1 (pl) 2006-02-06
CN1713912A (zh) 2005-12-28
KR20050085298A (ko) 2005-08-29
DE60321377D1 (de) 2008-07-10
RU2005121130A (ru) 2005-12-10
AU2003238399A1 (en) 2004-06-23
DK1569650T3 (da) 2008-06-30
ES2304514T3 (es) 2008-10-16
BR0316823A (pt) 2005-10-18
CA2506965A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
IL257622B (en) Methods and compositions for the treatment of persistent infections
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
NO20054369D0 (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
NO20041588L (no) Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
NO20055136D0 (no) Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer
SE0302304D0 (sv) Novel compounds
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
IS8072A (is) Miðlar úr bak kólesteról flutningi í meðferð á kólesterólhækkun
ITMI20042007A1 (it) "modulatori del ricettore gpr17 e loro impieghi terapeutici"
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals
ATE329591T1 (de) Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungen